资讯

Real-world data suggest that high-dose formulation ferric carboxymaltose injection (Injectafer; Daiichi Sankyo, Inc) may be a more cost-effective option for patients requiring IV iron therapy ...
About The Study: In patients with heart failure and iron deficiency, ferric carboxymaltose did not significantly reduce the time to first heart failure hospitalization or cardiovascular death in ...
a ferric carboxymaltose injection to treat iron deficiency. It also provides Liziana and Savaysa, direct factor Xa inhibitors; Minnebro, Olmetec, Olmetec Plus, Rezaltas, Sevikar, and Sevikar HCT ...